loader from loading.io

In the News.. Oral Meds for T1D, Dexcom API News, Closed Loop and Teens, Olympics and more!

Diabetes Connections | Type 1 Diabetes

Release Date: 07/23/2021

In the News.. Tzield approved for toddlers, generic Ozempic, Omnipod & Tandem updates, T1D Barbie honored... and more! show art In the News.. Tzield approved for toddlers, generic Ozempic, Omnipod & Tandem updates, T1D Barbie honored... and more!

Diabetes Connections | Type 1 Diabetes

It's In The News - where we bring you the top diabetes stories and headlines happening now. This week, Tzield approved down to age one and over, Omnipod trials for fully closed loop, Tandem approved for pregnancy, Eversense 365 launches in Europe, generic Ozempic in Canada, an award for the T1D Barbie and more.  Announcing Community Commericals! Learn how to Don't miss our in-person events:   Learn more about Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way to keep up with Stacey and...

info_outline
Inside Tandem’s Next Chapter:  Tubeless Mobi, 7-Day Wear & More with VP of Product Management Marisa Fienup show art Inside Tandem’s Next Chapter: Tubeless Mobi, 7-Day Wear & More with VP of Product Management Marisa Fienup

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections.. an update from Tandem Diabetes. Quite a few approvals and advances have already happened for Tandem this year, as the company looks ahead to the launch of their latest product, the Mobi Tubeless, not yet FDA approved. I’m talking to Marisa Fienup VP of Product Management about how this product is different from the original Mobi, the incorporation of the approved 7-day infusion set, asking your questions and more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing...

info_outline
The Fight to Save Levemir: Inside the Grassroots Push to Protect Insulin Choice show art The Fight to Save Levemir: Inside the Grassroots Push to Protect Insulin Choice

Diabetes Connections | Type 1 Diabetes

In 2024 Novo Nordisk announced it would discontinue Levimir insulin.. leaving many people scrambling and kind of stunned. There’s no other insulin on the market quite like this long-acting – and it turns out the community wasn’t letting it go without a fight. My guests are going to tell you more about why. I’m taking to Alison Smart, founder of Choice – her daughter lives with type 1 as well as two doctors: Florence Brown and Amy Valent. Dr. Brown is Co-Director Joslin and BIDMC Diabetes in Pregnancy Program, Assistant Professor of Medicine, Harvard Medical School. Dr. Valent...

info_outline
BONUS Episode: TempraMed wants to pair smart insulin  tracking with temperature protection show art BONUS Episode: TempraMed wants to pair smart insulin tracking with temperature protection

Diabetes Connections | Type 1 Diabetes

I’ve been talking to the folks at VIVI Cap for a few years now, it’s been fun watching their progress. I wanted to catch up and find out more about what they’ve been up to when it comes to insulin storage  – especially as we get closer to the hot summer months. They launched new products in the last year – smart insulin storage that helps you track dosing and a new case with more cooling protection. My guest is Ron Nagar, the founder and CEO of TempraMed, the company that makes the VIVI Cap. This podcast is not intended as medical advice. If you have those kinds of questions,...

info_outline
In the News.. Stem Cell Research Update, New Patch Pump Approved, GLP-1 Resistance Studied, Big Win T1D School Kids and more! show art In the News.. Stem Cell Research Update, New Patch Pump Approved, GLP-1 Resistance Studied, Big Win T1D School Kids and more!

Diabetes Connections | Type 1 Diabetes

It's In the News! Every other week we bring you the top diabetes stories and headlines happening now. This week's top stories: stem cell reserach updates, the Pivot patch pump gets FDA approval, GLP-1 Resistance research moves forward, T1D kids in VA get a big win, time of day for exercise matters, and much more! Don't miss our 2026 events - Announcing Community Commericals! Learn how to Learn more about  Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way to keep up with Stacey and the show...

info_outline
Eversense 365: Pump Integration and Real-Life Use For the One-Year CGM show art Eversense 365: Pump Integration and Real-Life Use For the One-Year CGM

Diabetes Connections | Type 1 Diabetes

We've got an update on Eversense—the CGM that sits just below the skin and lasts a year. This is the first time we’re talking to the folks from Senseonics, the company that makes Eversense, since they spun off from Ascensia. What's changed? It’s also the first time, we’re talking to someone who uses Eversense with an insulin pump – it’s now compatible with the twiist pump. I ask your questions about all of this – how’s the pump integration in real life, when will the next iterations of Eversense be out, their success in the type 2 market and much more. We're talking to Chief...

info_outline
More Than Babysitting: The Power of Type One Together with Raquel Baron show art More Than Babysitting: The Power of Type One Together with Raquel Baron

Diabetes Connections | Type 1 Diabetes

Today on Diabetes Connections.. a bonus episode all about finding support and community online and in real life. Seems to be a theme lately and I could NOT be happier. Type One Together started with one college student, a few babysitting jobs, and a realization that there was a need. Type One Together has become something much bigger – they’ll still help you find a sitter but they’re also a hub for T1D info, support and gatherings. I’m talking to the founder, Raquel Baron, about how they got there, what kind of help they provide and what’s next. This podcast is not intended as...

info_outline
In the News... Insulin Act, weekly basal approved, weight loss pill okayed, gene therapy for T1D and more! show art In the News... Insulin Act, weekly basal approved, weight loss pill okayed, gene therapy for T1D and more!

Diabetes Connections | Type 1 Diabetes

It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Senate Insulin Act moves forward, FDA approveds Awiqli for type 2 and and second oral GLP-1 pill, lots of updates on stem cell and gene therapy for type 1, updates from Beta Bionics, veterans group and Dexcom team up, and Omnipod features on Scrubs. Much more in the episode! Announcing Community Commericals! Learn how to  Learn more about  Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way...

info_outline
Grownup T1Ds: The Missing Support for Adults Living with Diabetes show art Grownup T1Ds: The Missing Support for Adults Living with Diabetes

Diabetes Connections | Type 1 Diabetes

There’s a reason we don’t call it juvenile diabetes anymore. We all know you grow up and T1D doesn’t go anywhere, and that you can be diagnosed at any age. But it often feels like adults are forgotten. I hope that’s not the case here—but I hear it all the time in the broader community. Kelly Dawes is working to change that. She’s started GrownUp T1Ds, a community built specifically for adults who’ve been living with type 1 for years and are finally finding connection, understanding, and support in a way they may never have had before. This podcast is not intended as medical...

info_outline
In the News... the In the News... the "Next Ozempic" moves forward, diabetes and dementia link, tech updates & approvals, ATTD news and more

Diabetes Connections | Type 1 Diabetes

It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Metformin may help stem macular degeneration, retatutride moves forward, T1D and demntia link studied, lots of news from ATTD and more! Announcing Community Commericals! Learn how to  Learn more about  Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more about...

info_outline
 
More Episodes
It's "In the News..." the only LIVE diabetes newscast! Our top stories this week:  Oral meds to prevent T1D move ahead, racial disparity in peds CGM use, what that Dexcom API news means, a new study with teens and Control IQ and a summer olympian talks about her recent T1D diagnosis.
Join Stacey live on Facebook each Wednesday at 4:30pm EDT!

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Get the App and listen to Diabetes Connections wherever you go!

Click here for iPhone      Click here for Android

Episode transcript below:

 

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.  As always, I’m going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more when you have the time.

XX

Our top story.. A new oral drug to prevent type 1 is moving along in trials. Right now it’s called IMT-002 – and put very simply - it’s meant to block a genetic trait that increases the risk for the disease and is seen in a majority of patients.

It’s a new way to think about treating type 1 – phase two studies could start next year. It’s thought that this could help with other auto-immune diseases as well.. the next condition these researchers want to tackle is celiac.

https://www.biospace.com/article/releases/im-therapeutics-reports-positive-results-in-safety-tolerability-and-mechanism-of-action-of-phase-1b-trial-of-lead-drug-imt-002-in-type-1-diabetes/

XX

Could the global rise in diabetes have an environmental component? In an Advances in Pharmacology article, researchers say routine exposure to chemicals that disrupt our endocrine systems play a role in triggering diabetes.

These researchers say "We often attribute patient's disease risk to individual choices, and we don't necessarily think about how systems and environments play into disease risk," They go on to say so-called lifestyle factors like exercise and diet fail to fully account for "the dramatic rise and spread" of diabetes.

https://www.ehn.org/environmental-factors-of-diabetes-2653768475/how-endocrine-disruptors-contribute-to-diabetes

XX

A new study shows Black children less likely to start or continue with a CGM after a type 1 diabetes diagnosis. These researchers at Children’s Hospital of Philadelphia or CHOP as it’s commonly known, show that a racial-ethnic disparity in CGM use begins within the first of year after diagnosis.

White children were more than two and a half times more likely to start CGM compared with Black children and twice as likely to start CGM compared with Hispanic children. There was a disparity even when broken down by types of insurance – commercial or government.

These researchers say social determinants including structural racism, are likely playing a role in disparities in care and outcomes

https://www.healio.com/news/endocrinology/20210719/black-children-less-likely-to-start-continue-cgm-after-type-1-diabetes-diagnosis

XX

Very large survey of women shows that half of those with type 1 or type 2 diabetes are not getting pre-pregnancy counseling. This study included more than 100-thousand women. Right now guidelines from many groups including the CDC and American Diabetes Association recommend providers offer women with diabetes health counseling before pregnancy to cut down on the increased maternal and infant risk associated with both conditions. These researchers hope to develop better tools for women & their doctors.

https://publichealth.berkeley.edu/news-media/research-highlights/women-with-diabetes-and-hypertension-dont-receive-pre-pregnancy-counseling/

XX

Big increase for time in range when kids use hybrid closed loop systems. We’ve heard about a lot of improvement, but in this study, the percentage of kids and teens with t1d spending at least 70% time in range… more than doubled after 3 months of using Tandem’s Control IQ system. This was a study of about 200 kids, median age was 14, and it was a real world study – where the kids went about their lives, not in a clinical setting, and the researchers pulled the data electronically.

Interestingly, sleep mode use increased through 6 months, while the exercise mode was used less over time.

Kids with an A1C over 9 saw the most improvement. Those with an A1C under 7 didn’t see much of a change.

https://www.healio.com/news/endocrinology/20210714/more-youths-with-type-1-diabetes-meet-timeinrange-goal-with-hybrid-closedloop-system

XX

Dexcom gets FDA clearance for real time APIs.. what does that mean? Third party companies like Fitbit or Sugarmate which have long integrated Dexcom data have been doing so on a bit of a delay. Now they can do so in real time.

API stands for Application Programming Interface, which is a software intermediary that allows two applications to talk to each other.

Dexcom’s Partner Web APIs will allow users to view all of their diabetes care data in one place to enable in-the-moment feedback and adjustments, the company said in the announcement.

 

https://www.mobihealthnews.com/news/dexcom-gets-fda-nod-its-new-api-integration

 

XX

Cool new exhibit at Banting House – recent guests of the podcast and museum celebrating the birthplace of insulin.

They’re set to open up again this week – the first time since March 2020 – and there’s a new computer generated exhibit. It does work outside.. In the square where Dr. Banting’s statue stands. Giving visitors a virtual glimpse at the life and work of the man credited for the discovery of insulin. If you haven’t visited – it’s in Canada – or seen the museum, I highly recommend a spin around the website, we’ll link it up.

XX

Summer Olympics are kicking off and by now you’ve probably heard that American trampoline gymnast Charlotte Drury was just recently diagnosed. She found out she had type 1 weeks before the 2021 Olympic qualifying trials, she revealed on Instagram last week. she and her coach pressed on and she basically got back into things within three weeks. She posted this photo of herself wearing the Dexcom. Drury is the first American woman to win a gold medal in trampoline at a World Cup

That’s Diabetes Connections – In the News.  If you like it, share it. And feel free to send me your news tips. Stacey @ diabetes dash connections dot com.

Please join me wherever you get podcasts for our next episode -Tuesday –  I’ll share my conversation with Gold Medal Olympian Gary Hall Jr – when he was diagnosed in 1999 he was told to give up swimming. He didn’t and he talks about why.. and how he overcame what was conventional wisdom for athletes at the time. This week’s show is the story of Jack Tierney, diagnosed in 1959 with type 1 he’s 81 and he says he’s never felt better.

Thanks and I’ll see you soon